Interventional Oncology Devices | Market Insights | Japan | 2023
The Japanese interventional oncology device market saw a relatively limited impact of the COVID-19 pandemic, owing to the less elective nature of cancer procedures and progressively deteriorating disease conditions. The market will grow slowly due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines and increasing developments in anticancer drugs, limiting the growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in Japan across a 12-year period.
